PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
International Journal of Mycobacteriology10.1016/j.ijmyco.2014.10.016201544-5The role of drug susceptibility testing in controlling drug resistant tuberculosis: Challenges and possibilitiesSven Hoffnerhttp://api.elsevier.com/content/article/PII:S2212553114001241?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S2212553114001241?httpAccept=text/plain
BioSocieties10.1057/biosoc.2011.2320127150-71New diagnostics for multi-drug resistant tuberculosis in India: Innovating control and controlling innovationNora Engelhttp://link.springer.com/content/pdf/10.1057/biosoc.2011.23.pdf, http://link.springer.com/article/10.1057/biosoc.2011.23/fulltext.html, http://link.springer.com/content/pdf/10.1057/biosoc.2011.23, http://link.springer.com/content/pdf/10.1057/biosoc.2011.23.pdf
PLoS ONE10.1371/journal.pone.0089822201493e89822Disease Control Implications of India's Changing Multi-Drug Resistant Tuberculosis EpidemicSze-chuan Suen, Eran Bendavid, Jeremy D. Goldhaber-Fieberthttp://dx.plos.org/10.1371/journal.pone.0089822
Inflammopharmacology10.1007/s10787-010-0072-22010193131-137Drug-resistant tuberculosis: an insurmountable epidemic?Amitabha Chakrobortyhttp://link.springer.com/content/pdf/10.1007/s10787-010-0072-2.pdf, http://link.springer.com/article/10.1007/s10787-010-0072-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10787-010-0072-2
Indian Journal of Tuberculosis10.1016/j.ijtb.2021.04.0082021Drug resistant tuberculosis: Current scenario and impending challengesShivendra Singh Dewharehttps://api.elsevier.com/content/article/PII:S0019570721000809?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0019570721000809?httpAccept=text/plain
Tuberculosis10.1016/j.tube.2017.09.0052017107137-143Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implicationsSharana Mahomed, Kogieleum Naidoo, Navisha Dookie, Nesri Padayatchihttps://api.elsevier.com/content/article/PII:S147297921730094X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S147297921730094X?httpAccept=text/plain
Microbial Drug Resistance10.1089/mdr.2020.02402020Emergence of Specific gyrA Mutations Associated High-Level Fluoroquinolone-Resistant Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Cases in North IndiaPravin Kumar Singh, Urmila Singh, Amita Jainhttps://www.liebertpub.com/doi/full-xml/10.1089/mdr.2020.0240, https://www.liebertpub.com/doi/pdf/10.1089/mdr.2020.0240
Nature Medicine10.1038/nm1101-117320017111173-1173Timebomb: The Global Epidemic of Multi-Drug Resistant TuberculosisDenise Kirschnerhttp://www.nature.com/articles/nm1101-1173.pdf, http://www.nature.com/articles/nm1101-1173, http://www.nature.com/articles/nm1101-1173.pdf
The Lancet10.1016/s0140-6736(07)61614-6200737095971464-1465Controlling extensively drug-resistant tuberculosisTravis C Porco, Wayne M Getzhttps://api.elsevier.com/content/article/PII:S0140673607616146?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673607616146?httpAccept=text/plain
Indian Journal of Tuberculosis10.1016/j.ijtb.2021.08.039202168S108-S114Determinants of drug resistant & drug sensitive tuberculosis patients from North India-a case control studySonu Goel, Deep Thakur, Amarjeet Singhhttps://api.elsevier.com/content/article/PII:S0019570721001815?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0019570721001815?httpAccept=text/plain